News

Published on 23 Nov 2022 on Zacks via Yahoo Finance

Palisade Bio's (PALI) LB1148 Gets FDA Fast-Track Designation


Article preview image

Shares of Palisade Bio PALI were up 81.08% during market hours after the company announced that its lead asset, LB1148, a protease inhibitor has been granted Fast Track designation by the FDA for accelerated return of bowel function following gastrointestinal (GI) surgery.However, the stock has plunged 100% in the year-to-date period compared with the industry’s fall of 17.8%.

Zacks Investment ResearchZacks Investment Research

Image Source: Zacks Investment Research

NASDAQ.PALI price evolution
NASDAQ.ETON price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Earnings call: Eton Pharmaceuticals reports robust Q4 growth By Investing.com

Eton Pharmaceuticals , Inc. (NASDAQ:ETON) announced a significant increase in revenue and positiv...

Investing.com 15 Mar 2024

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript March 14, 2024 Eton Pha...

Insider Monkey via Yahoo Finance 15 Mar 2024

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

Revenue Growth: Q4 product sales and royalty revenue surged by 109% year-over-year to $7.3 millio...

GuruFocus.com via Yahoo Finance 14 Mar 2024

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.09 per share versus the Za...

Zacks via Yahoo Finance 14 Mar 2024

Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards?

Eton Pharmaceuticals ETON is expected to release its fourth-quarter 2023 results soon. Eton is a ...

Zacks via Yahoo Finance 26 Feb 2024

Individual investors account for 59% of Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) ownership, while ...

Key Insights Eton Pharmaceuticals' significant individual investors ownership suggests that the k...

Simply Wall St. via Yahoo Finance 19 Feb 2024

One Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Analyst Just Made A Major Cut To Next Year's Estimates

Market forces rained on the parade of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) shareholders today...

Simply Wall St. via Yahoo Finance 13 Dec 2023

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2023 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2023 Earnings Call Transcript November 9, 2023 Eton P...

Insider Monkey via Yahoo Finance 11 Nov 2023

Declining Stock and Solid Fundamentals: Is The Market Wrong About Eton Pharmaceuticals, Inc....

Eton Pharmaceuticals (NASDAQ:ETON) has had a rough week with its share price down 16%. But if you...

Simply Wall St. via Yahoo Finance 11 Nov 2023

Eton Pharma (ETON) to Report Q3 Earnings: What's in the Cards?

We expect the investors to focus on Eton Pharmaceuticals’ ETON product sales numbers when the com...

Zacks via Yahoo Finance 23 Oct 2023